INTRODUCTION

THE DEVELOPMENT OF THE PRETERM INFANT IS FRE-QUENTLY ASSESSED USING THE TERM INFANT AS A REFERENCE. FOR EXAMPLE, WHEN PRETERM INFANTS
are 38 weeks postmenstrual age (PMA), they are compared with term infants of similar age. One problem with this comparison is that the stress of preterm birth with its accompanying morbidity is confounded with the effect of prolonged extrauterine existence. An alternative approach would be to assume that the stress of preterm birth, treatments with supplemental oxygen, mechanical ventilation, or corticosteroids, together with prolonged extrauterine existence confer an advantage or a disadvantage that could result in advances, delays in development, or both. In that case, it would be more appropriate to establish what is normal physiologic development for the preterm infant rather than to focus on the comparison with term-born infants.
Maturation of sleep architecture follows a well-described course throughout infancy, with a gradual decrease in rapid eye movement (REM) or active sleep and a simultaneous increase in quiet sleep. 1, 2 Scher and his investigative team 3 reported on a sizable sample of asymptomatic preterm infants in terms of electroencephalogram (EEG)-sleep analysis. They demonstrated how, compared with term-born infants, the preterm cohort showed advances and delays in a host of variables that were present into early infancy, such as alpha-and beta-range spectral values of the EEG. Morbidity issues have typically not been evaluated. We previously reported that preterm infants with well-documented prolonged apnea and bradycardia in the neonatal intensive care unit (NICU), just prior to discharge, exhibit more sustained quiet sleep without interruptions by awakenings at 44 weeks PMA than their age-matched controls, suggesting an acceleration in their development or, alternatively, a blunting of self-protective mechanisms. 4 Subsequent to that study, the administration of maternal steroids to enhance lung maturation has become routine. 5 A number of reports have shown that antenatal steroids accelerate gastrointestinal and renal systems, although findings about the brain vary. [6] [7] [8] [9] Maturation of the auditory brainstem evoked potential is not affected, 9 but the evoked somatosensory response is, at least on postnatal day 1, with normalization from 1 week onward. 10 In young rats, eyes open a day sooner than in the unexposed group, but locomotion is adversely affected. 11 Whether antenatal or postnatal steroids affect sleep-state development in infants has not been established. Shinwell et al have expressed a concern about the long-term sequelae of steroid treatment. 12 As part of the protocol of the Collaborative Home Infant Monitoring Evaluation (CHIME), a national study with 5 clinical sites, overnight infant polysomnograms (PSG) have been collected. Quality criteria have been fulfilled in 399 PSGs. The first objective of the present study is to examine the similarity in sleep architecture in infants at perceived increased risk for sudden infant death syndrome (SIDS) compared with healthy term infants. The second objective is to confirm previous findings of sleep and waking in preterm infants, in particular to uncover delays or advances in sleep architecture of preterm compared with term infants. The third objective is to determine the effects of ventilatory support, an estimate of morbidity, and gestational age on the rate of sleep maturation. The fourth objective is to examine whether steroid administration affects sleep maturation. In addition, the potential confounding influences of sex, being small for gestational age (SGA), and maternal smoking during pregnancy were assessed.
METHOD Participants
The Institutional Review Board at each of the 5 clinical sites approved the study. An informed consent was obtained from the mothers of 201 preterm infants, defined as a gestational age ≤ 37 weeks, and 198 term infants for participation in CHIME and the collection of 1 overnight, in-hospital PSG. Of the preterm infants, 193 underwent their PSG at or after a PMA of 34 but before 54 weeks. An additional 8 preterm infants had their PSG either earlier or later. Preterm infants of 34 weeks or less gestation at birth were excluded from the CHIME study if they had any of the following: pneumonia confirmed by chest radiograph; home treatment with (1) continuous oxygen, (2) bronchodilators, (3) diuretics, (4) steroids, (5) medications for gastroesophageal reflux or seizure; congenital heart disease except asymptomatic patent ductus arteriosus, atrial septal defect, or small muscular ventricular septal defect; ventricular peritoneal shunt; congenital brain anomaly that would result in non-SIDS diagnosis in the event of sudden death; chromosomal abnormality; midfacial hypoplasia or cleft palate; inborn error of metabolism; caregiver currently using illicit drugs; or parental inability to communicate (language barrier or no telephone). Among both the term and the preterm groups were subsequent siblings of SIDS (SSS) and infants with an apparent life-threatening event with unknown etiology, thus designated apnea of infancy (AOI).
SIDS Risk Group Comparisons
The cross-sectional PSGs of 88 healthy term (HT) infants, 51 term infants with AOIs, and 59 term SSS were compared. Maternal and infant characteristics are presented in Table 1 .
Maturational Comparisons
The cross-sectional PSGs of 193 preterm infants were divided into 5 age intervals (35-38, 39-42, 43-46, 47-50, and 51-54 weeks PMA). All of the sleep variables outlined below were examined as a function of PMA interval at the time of PSG. Subsequently, the cross-sectional PSGs of 112 term infants were compared with those of 119 preterm infants at the following PMA intervals (38-43, 44-49, 50-55 weeks). Maternal and infant characteristics of the preterm cohort are listed in Table 1 as well.
The Effect of Ventilatory Support, Steroids and Gestational Age on Sleep Architecture
A subset of 42 preterm infants who had experienced mechanical ventilation and/or received supplemental oxygen was matched with an equal size subset that had experienced none or a minimal number of days of such treatments. The number of treatment days in the exposure group ranged between 5 and 74. The mean number of days with mechanical ventilation was 20.5, and the mean number of days on supplemental oxygen was 28.0. Each infant in the exposure group was matched with a control of similar gestational age (± 2 weeks) and similar PMA at the time of the PSG (± 2 weeks). The first infant on the list after the index case, who fit these criteria, was selected. The mean for the matched, low mechanical ventilation subset was 0.3 days, and that for supplemental oxygen was 2.2 days duration. In the matched control group, 32 infants had no mechanical ventilation, 7 infants had 24 hours or less, 2 had 48 hours, and 1 had 72 hours. Of these same infants, 20 had 24 hours or less of supplemental oxygen, 15 had 60 or more hours, and 2 had 8 and 12 days, respectively. The latter 2 were paired with index infants who had received oxygen for 41 and 72 days. The mean gestational ages of the exposure and the control groups were, respectively, 29.9 and 30.5 weeks. It was impossible to find an untreated match for the additional 36 youngest infants with a PSG whose mean gestational age at birth was 25.9 weeks. These were not included in the above matched groups.
Steroid administration to the mother occurred independently from that given to the infant, although a partial overlap was present. Infants whose mothers had received steroids before delivery (n = 32) were matched with infants of similar gestational age and PMA with no steroid exposure either prenatally or in the nursery. Similarly, 28 infants who received steroids in the NICU were matched by gestational age and PMA at the time of the PSG with those who had no steroids in the NICU, regardless of maternal steroid exposure. Seventeen additional infants with a PSG whose gestational age was ≤ 26 weeks could not be matched.
For an analysis that targeted the effect of gestational age on sleep architecture, 2 subsets were identified consisting of infants with a gestational age ≤ 27 weeks who underwent a PSG between, respectively, 36 and 38 weeks (n = 12) and 39 and 41 weeks (n = 13). These subsets were compared with 2 gestational age groups of 28-31 weeks who underwent PSGs during the same 2 PMA intervals as the first subsets (n = 28 and n = 24, respectively).
The Effect of SGA, Sex and Maternal Smoking During Pregnancy on Sleep Architecture
Thirty SGA babies were identified and each matched with a control of similar gestational age and PMA at the time of the PSG, following the same strategy as described above. The full range of dependent variables was examined in this cohort as in the study of the effect of sex upon sleep architecture (Table 1) . Forty-four mothers smoked 1 or more cigarettes a day during pregnancy.
Monitoring Procedure
Personnel at the sleep or respiratory physiology laboratories in Los Angeles, Chicago, Cleveland, Honolulu, and Toledo underwent training in a standardized protocol for obtaining PSG data. Extensive control and feedback procedures were implemented to ensure comparability of the data. Each infant was admitted to the laboratory in time for a 9:00 PM onset of calibration and recording. Often the infants were fed during preparation of monitoring and application of electrodes. Throughout the remainder of the night, a demand-feeding schedule was followed with opportunity for breastfeeding. In some laboratories, mothers or caregivers were provided with a recliner and remained in the recording room with the instruction to be as quiet as possible; in others, a separate room was provided for the mother or caregiver where she could rest. Newborns were typically wrapped in a blanket, while cloth bands around the arms of older infants were secured with safety pins.
Monitoring was carried out in a darkened room with the recording equipment in an adjacent room. The infants were placed in a supine or side-lying position, and, in most sites, they were observed with the help of a low-illumination camera and monitor. Activities such as closing and opening of eyes, startles, crying, movements, and staff interventions were charted. PSG personnel made annotations on the record to establish episodes of behavioral wakefulness.
Physiological Recording Method
Sleep variables included 2 EEG derivations (C4-A1 and C3-A2 according to the International 10-20 system), a chin electromyogram, 2 electrooculograms, and a movement sensor attached to the diaper. Inductance plethysmography was used to measure thoracic and abdominal breathing excursions. In addition, a CO 2 monitor sampled expired CO 2 through a miniature cannula taped under the infant's nostril. This cannula also contained an oronasal thermistor. The electrocardiogram was recorded with 2 disposable electrodes placed under the clavicle and equidistance from the midline. Oxygen saturation values (Nellcor, Pleasanton, Calif) were obtained with a pulse oximeter probe taped to the infant's foot. 13 The data were recorded on an ALICE 3 System (Healthdyne, Marietta, GA) and stored on a Sony optical disk.
Data Analysis
After local review, optical disks were shipped to the central data analysis center in Boston, where trained personnel analyzed all PSG tracings. These technicians visually scanned the recordings. On a 30-second basis, the EEG (mixed and low-voltage irregular activity, high-voltage slow activity, and trace alternant 14 ), electrooculogram, the movement, and the breathing channels were each examined separately and assigned a code. These codes were subsequently entered into computer files. Reliability studies have been published elsewhere. 15 Smoothing of the data was accomplished in 2 steps, first, at the level of the individual variable, where if an eye movement was present in one 30-second epoch, it was considered present in the adjacent epochs as well. This decision is predicated on the knowledge that eye movements are phasic, and demanding that they be present in each 30-second epoch of active sleep would unrealistically fragment sleep states. A CHIME sleep-state algorithm was developed based on EEG, respiratory variability, eye movements, and body movements conforming to either active sleep or quiet sleep. 14, 16 The data-collection personnel derived wakefulness epochs from the movement sensor and annotations made during the actual recordings. The second step of state smoothing was then accomplished with a 5-epoch moving window based on the state representing the majority within the window. If there was no majority, then the five 30-second epochs were assigned indeterminate status. A previously published report by our group evaluated the typical smoothing strategies encountered in the infant sleep literature, including the one used here. 16 Sleep states as a percentage of total recording time, longest state episode, number of 10-minute or longer episodes, and mean duration of each state were calculated as a function of (1) SIDS risk status (2) gestational age status of preterm infants (3) SGA status and (4) preterm or term infant group. The percentages of active sleep and quiet sleep of the total recording time were derived for each matched group. Sleep efficiency (percentage of active sleep plus percentage of quiet sleep) was selected as an additional dependent variable in SIDS risk groups, as a function of term and preterm status, and to examine the influence of maternal smoking, SGA, and sex. Statistical comparisons were performed with the help of a general linear model type III sum of squares, assuming an unequal number of entries in each cell, a 1-way analysis of variance and paired Student t tests. In some cases, when matched pair results were not significant, a power analysis was performed to obtain least significant numbers and values to ascertain the effect of the sample size.
RESULTS
Comparison of Healthy Term With Term SIDS Risk Groups
There were no significant differences in any of the sleep variables of healthy term and AOIs (Table 2) . After adjusting for age, 3 significant differences characterized the sleep of SSS, compared with healthy term infants: a smaller percentage of quiet sleep (34.43% ± 10.96% vs 43.07% ± 13.29%), the mean longest quiet sleep episode was reduced compared with healthy term (27.03 minutes ± 9.92 vs 34.07 minutes ± 13.17), and the mean number of sustained periods of wakefulness of 10 minutes or longer was slightly higher in SSS than in healthy term ( Table  2) .
Maturation of Sleep States in Preterm Infants
The preterm infants of 34 to 37 weeks PMA exhibited immature sleep architecture compared with preterm infants who had reached a PMA of 42 to 45 weeks. Quiet sleep percentages of total recording time increased from 18% to 30% (P < .0001) accompanied by a decrease in active sleep percentages from 41% to 26% (P < .0001). No maturational effect was observed in either the percentage of indeterminate or awake time. Percentages of quiet sleep continued to rise (47%) in preterm infants up to 54 weeks PMA, accompanied by a decline in active sleep to 21% (Figure  top and Table 3 ).
The number of episodes of quiet sleep of at least 10 minutes in duration increased (P < .0001); they doubled between 34 to 37 and 42 to 45 from 2 to 4 and continued to rise significantly to 6 after 46 to 49 weeks PMA. A decrease in the number of active sleep episodes of at least 10 minutes in duration was observed during this age span, from 5 between 34 and 37 weeks to 2 between 50 and 53 weeks PMA. Only the mean duration of all quiet sleep episodes showed a significant trend (P < .0001) with a rise from 6 minutes in the youngest age group to 11 minutes in the oldest.
The longest mean episode of quiet sleep was 17 minutes in preterm infants between 34 and 37 weeks PMA, compared with 26 minutes in the 42-to 45-week group (P < .0001). This value continued to rise until 54 weeks PMA. The decrease in the duration of the longest episode of active sleep from 31 minutes in the youngest preterm infants to 17 minutes in the oldest preterm infants (50-53 weeks PMA, P < .0002) was slower. There was, however, an abrupt drop of 11 minutes after the equivalent term age (Figure bottom and Table 3 ).
Comparison of Preterm and Term Infants
With 3 exceptions, none of the comparisons between preterm 1431 
Sleep States as Percentage of Total
Recording Time infants ≥ 38 weeks PMA and term infants (healthy term and AOI) at comparable PMA yielded significant differences ( Table 4) . The exceptions were the number of quiet 10-minute or longer sleep episodes (P < .016); preterm infants had an average of 5.9 (±2.4) of these quiet sleep episodes per overnight recording, compared with 3.2 (± 2.2) in term infants. The mean duration of indeterminate epochs (1.4 minutes ± 0.5 vs 1.3 minutes ± 0.6) as well as the longest indeterminate epoch (4.1 minutes ± 2.9 vs 3.6 minutes ± 3.2) was elevated in preterm infants as well. None of the independent variables studied had any influence on sleep efficiency. However, sleep efficiency increased significantly with increasing PMA intervals (P <
The Effects of Ventilatory Support, Steroid Administration and Gestational Age on Sleep Architecture
A review of the infant medical histories revealed that the group who had undergone appreciable ventilatory support exhibited more morbidity. Thus, besides the need for ventilatory support, 48% had asymptomatic patent ductus arteriosus versus 10% in the group with minimal support (infants with symptomatic patent ductus arteriosus were excluded from the CHIME study. Nineteen percent had intraventricular hemorrhage grade I and II (in addition, 1 infant had grade III). In the minimalventilatory-support group, the number was 12%. The numbers for periventricular leukomalacia were 7% and 2%, respectively; necrotizing enterocolitis (10%) was only found in the ventilatory- (14) 39 (13) 26 (9) 26 (11) 21 (7) < .0001 % indeterminate 8 (5) 6 (5) 5 (4) 6 (5) 6 (6) .09 % awake time 34 (13) 32 (11) 38 (14) 32 (11) 27 (15) Infants with ventilatory support in the NICU exhibited immature sleep architecture compared with matched controls that had experienced no or minimal ventilatory support. The percentage of active sleep was 42% (± 13.0%) in the former compared with 34.4% (± 12.5%) in the latter (F 1,82 = 7.5, P < .001). There was no difference in percentage of quiet sleep (Table 5) .
Steroids in the NICU had no influence on sleep architecture, as measured by the PSG (Table 5 ). Maternal steroids similarly had no effect. Since the least significant number for the NICU steroid matched groups for percentage of active sleep was 93 rather than the 42 that were actually available, the maternal and NICU exposure were combined. The means were 36.7% for exposed infants and 37.8% for those not exposed. In that case, the power analysis revealed that the least significant number of cases to possibly yield a significant finding was 19,190 cases.
When they reached a PMA of 36 to 38 weeks, infants of 27 weeks of less gestational age still showed a delay in their sleep architecture, with 14.6% of quiet sleep, compared with 23.1% in infants born with a gestational age of 28 to 31 weeks (F 1,32 = 8.1, P < 0.001, Table 5 ). Two other groups of the same gestational ages who had their PSGs at 39 to 41 weeks PMA exhibited 21.0% and 26.6% of quiet sleep, respectively (F 1,33 = 4.2, P <.09), a similar but nonsignificant trend. There were no significant differences in active sleep percentages. The sleep architecture of infants born at a later gestational age-between 28 and 31 weeks, who underwent their PSG recordings also between 36 to 38 weeks PMA and 39 to 41 weeks PMA-could not be differentiated statistically either.
The Influence of SGA, Sex, and Maternal Smoking
The 30 SGA infants in this study exhibited a significant increase in the percentage of active sleep (P < .03) compared with age-matched appropriate-for-gestational-age infants (38.28 ± 2.40 vs 31.52 ± 13.61). Sex had no effect on sleep architecture. Smoking during pregnancy consistently influenced wakefulness. The mean duration of wakefulness (17.6 minutes ± 13.7 vs 16.6 minutes ± 12.3), as well as the longest episode of wakefulness (57.9 minutes ± 31.6 vs 55.4 minutes ± 28.3), was prolonged in infants born to smoking mothers (P < .034 and .004, respectively). A comparison of sleep-state percentages in ventilated babies whose mothers smoked during pregnancy, versus the absence of smoking, revealed a normalizing of the delay discussed in above (Table 5) .
DISCUSSION
The sleep architecture of SSS was significantly different from that of healthy term and AOI, the latter 2 being comparable. The findings suggest a delay in maturation in these SSS. This prompted an elimination of this risk group for the comparison between preterm infants and term infants at comparable PMA. Preterm infants between 34 and 38 weeks PMA exhibited immature sleep-state patterns when they were compared with preterm infants that had reached term PMA. The latter exhibited similar sleep architecture as term-born infants, except for more episodes of long awakenings between 50 and 54 weeks PMA, a finding that has been reported by others, quite sleep episodes > 10 min and more indeterminate sleep. [17] [18] Preterm infants with the youngest gestational age lagged behind the older ones even if they were measured at the same PMA. There was no apparent effect of steroids on sleep architecture, whether given to the mother or the newborn. Early gestational age, ventilatory support, and neonatal steroid administration were strongly correlated. With current standards of treatment, these influences cannot be teased apart. Significant ventilatory support was associated with a delay in the maturation of sleep architecture. Interestingly, maternal smoking in ventilated babies undid the delay mentioned above. Maternal smoking prolonged waking variables in the overall cohort of term and preterm infants.
The potential confounding effect of postneonatal side smoke or feeding on sleep architecture is worth studying, but it requires a very detailed follow up of the infants. The CHIME database probably contains adequate information that requires careful scrutiny and several analyses, better performed in a separate paper. The use of caffeine, on the other hand, its dose, timing, and adherence, were insufficiently documented to be of value for an examination as a potential confounder.
This study provides preliminary answers to the original question raised in the Introduction as to whether it would be most appropriate to establish what is normal physiologic development for the preterm infant, rather than to focus on the comparison with term-born infants. Three developmental courses can be observed: that of the term-born infant, that of the asymptomatic preterm infant, and that of the preterm infant with significant ventilatory support. The brain of the asymptomatic preterm infant seems to follow its own developmental schedule, at least in terms of sleep development; in-utero or ex-utero existence seems to make little difference. The baby matures normally, and, using the term baby, as the reference seems appropriate because sleep architecture is virtually identical at the equivalent PMA of 38 to 40 weeks and remains so. With larger magnification, however, even these infants who have seemingly caught up exhibit more subtle delays and advances that can be demonstrated up to a PMA of 43 to 53 weeks. 3, 19 In our study, very young preterm infants and those who received significant ventilatory support indicative of morbidity exhibited a measurable delay in the maturation of sleep architecture. For these infants, the behavior of their fellow asymptomatic preterm infants may be the most appropriate reference.
Past findings of alterations in sleep architecture in infants at increased risk for SIDS have been equivocal. Navelet et al 20 combined what were then called near-miss infants with subsequent siblings and reported a decrease in awakening and a higher amount of active sleep, but these findings seemed to apply mostly to near-miss infants. Challamel et al 21 found fewer awakenings in the latter, but, once awake, these infants remained so longer. We published a systematic study of 25 SSS whose PSGs were virtually the same as those of a carefully matched control group. In that study, none of the variables examined here were different. 22 In the present study, differences centered especially on a reduction in quiet sleep, suggesting a delay in maturation. A delay in maturation is also suggested by a relative decrease in quiet sleep that others have observed in infants with apparent life-threatening events. 23 In the present study, the sleep architecture of infants with AOI could not be differentiated from those of healthy term infants. The best explanation for these discrepancies is that our cohort was not only the largest ever studied under the same protocol, but that it comprised infants with AOI in whom explanations for the apparent life-threatening event had been ruled out. Most previous studies were performed before this diagnosis was generally accepted.
Most studies in the literature have documented the physiologic adaptations such as delays and advances in asymptomatic preterm infants. By contrast, Karch and coworkers 24 explicitly examined sleep architecture in 3 preterm cohorts, 2 of which received assisted ventilation, with sample sizes of 24, 14, and 23, respectively. All were monitored between 30 and 37 weeks PMA. Unlike our results, they found a larger proportion of quiet sleep and longer durations of quiet sleep in symptomatic infants when studies at 30 and 36 weeks were combined. Scher et al 25 compared preterm infants with chronic lung disease at term age with 2 groups: similarly aged preterm infants without lung disease and term-born infants. Their finding of a reduction in percentage of active sleep was different from either the findings of Karch and co-workers and ours. In our study, controls were matched for gestational age and PMA, and the latter varied between 33 and 57 weeks PMA. Even when only matches of infants with PSG at term PMA were examined, the increase of active sleep percentage in the infants with ventilatory support persisted. Some of these differences may be accounted for by the changes in NICU support in the more than 20 years since publication of the paper by Karch and coworkers. The morbidity of surviving infants in the CHIME study during their nursery stay was almost certainly higher. Maternal smoking during pregnancy, rather than exacerbating the delay in maturation, seemed to compensate for it.
An effect on sleep of steroids, which are often used in clinical practice, was not measurable in our cohort. Neither prenatal nor postnatal steroid exposure had a significant effect. Since a power analysis suggested that a sample twice the size of the 42 exposed infants might result in significant findings, we collapsed maternal and infant steroid-exposure groups. This strategy added measurably to the variance. The least significant number of subjects to obtain a potentially significant result was extremely large. This study does not establish unequivocally that steroids per current clinical protocol have no or little effect on subsequent sleep behavior, but this conclusion is nonetheless likely. Latencies of the auditory brainstem averaged evoked potential are similarly unaffected. 9 Although, on the first day after birth, the somatosensory evoked response showed a slight change in infants prenatally exposed to steroids, this effect was extremely transient and had disappeared after 1 week. 10 When the PSG in our study was performed, the postnatal age of every preterm infant, exceeded 1 week by far.
What is the significance of advances and delays from both a research and clinical point of view? The age at which these advances and delays, collectively coined "dysmaturity" by Scher, 3 have occurred coincide with the typical age window of SIDS-between 42 and 52 weeks PMA in preterm infants and 10 and 12 weeks of postnatal age in the term infant. SIDS is far more prevalent in preterm infants than in term-born infants, and the rate increases with decreasing gestational age. 26 It is also the age that a number of nonmonotonic physiologic changes occur in both the central and autonomic nervous systems, suggesting a profound reorganization of neuronal circuits and their interaction during a discrete age period that represents a risk time for SIDS. 27 Change and variability are a hallmark of infancy; in both infancy and adulthood, they imply flexibility, or even plasticity, but, in excess, such a reorganization may imply risk.
Variability in sleep architecture remains the norm, as has been amply demonstrated previously. In 1982, we published a tabulation of influences on sleep that amounted to 2 dozen, a number that has only risen. 28 Another manifestation of variance is the inability to replicate findings, even within sleep laboratories. 22 Preterm infants prior to nursery discharge experience, in their own way, a highly stimulating environment, and their sleep behavior shows variance similar to that of term infants.
The developmental trend in sleep and waking behavior, however, is robust despite these variances. Sleep resembles the neural organization of language, a preprogrammed capability that cannot but manifest itself within a certain time window. Case studies in conjoined twins, who are always identical, reveal similarities in these maturational sleep trends, yet dissimilarities in the temporal distribution of sleep and individual sleep states. 29 Thus, even though the genetic and environmental input in such infants is virtually identical, each exhibits aspects of his or her own sleep architecture; in other words, infant temperament and other idiosyncrasies can have profound effects. In the 1980s, Monod and Guidasci 30 examined the sleep-waking behavior of severely damaged neonates and revealed surprisingly normal values in some, but by no means all, of these infants. Against the background of such variance, is it reasonable to expect that we can unequivocally attribute outcome to these small transient adaptations, confounded with numerous social and environmental influences? Yet, it seems unwise to jettison all attempts to find potential central nervous system predictors of infant outcome in light of the high stakes.
Our study had ended for most infants around 6 months of age. Maturation in sleep architecture will, of course, continue beyond that age. During the last decade, a significant body of information has accumulated that suggests that sleep, in particular, although not exclusively, REM sleep, is crucially involved in memory consolidation, as well as in neural development. The delays and advances in the maturation of sleep architecture can be considered manifestations of plasticity. The phasic activity of REM sleep in infancy peaks at the time of the most rapid neural development. 31 It is, however, not just the temporal association that lends credence to the contemporary variant of what Roffwarg et al. termed the ontogenetic hypothesis, 32 the idea that phasic activity during REM sleep provides an important source of endogenous neural activity that, together with exogenous input, sculpts and reinforces neural networks in the developing brain. In fact, the contemporary variant of that hypothesis posits that the endogenous neural activity might even afford protection against excessive experience-driven plasticity. Findings in maturation of the visual system in kittens, with manipulation of monocular deprivation, REM-sleep deprivation, and pharmacologic elimination of pontogeniculooccipital spikes, has suggested a likely causal role for REM sleep in neural development. 33 Synaptic mechanisms are extremely malleable and intrinsically unstable. The neural networks that underlie early cognitive and motor behavior in status nascendi could be considered the epitome of instability. In that light, the minor adaptations in sleep architecture that can be observed, for instance a decrease in the percentage of time spent in active sleep in SGA infants, may diminish endogenous stimulation at an inopportune time. If, indeed, REM sleep or active sleep controls neural activity, then a lack may have more deleterious consequences than previously appreciated. In this context, the role of cytokines other than the anti-inflammatory variety in synaptic plasticity is intriguing. 34 Preterm infants have been found with elevated levels of anti-inflammatory cytokines that, upon further search, may be correlated with cytokines involved in synaptic plasticity. 35 There is evidence that some advances and delays predict developmental outcome. 3, 36 During the last decades, enormous progress has been made to ensure the survival of micro-preemies with a gestational age of 23 to 26 weeks. It has become clear that even though their central nervous systems are relatively undamaged and severe encephalopathies are not the rule, between 25% and 70% of these infants wind up with neurologic and developmental handicaps, depending on their gestational age. [37] [38] [39] Why this is so is not well understood, and there is a scarcity in treatment strategies. Might this cohort be particularly suited to examine the validity and sensitivity of EEG/sleep variables in the prediction of neurologic and developmental outcome? The term catch-up seems to take on an added significance because it defines a rate of maturation. These low-birth-weight infants could be compared with asymptomatic preterm infants at a PMA of 30 to 32 and 34 to 36 weeks and at several later intervals to establish a timetable for the nature and appearance of these adaptations and their respective catch-up times. It might answer such questions as whether and how the timetable differs in the youngest infants who have overcome medical illnesses in their early life.
In conclusion, the asymptomatic premature infant is not obviously delayed in sleep architecture compared with the term infant. Increased waking behavior throughout the first months at home constitutes an exception. By and large, these infants mature appropriately to become equivalent to the term infant at 40 weeks PMA. Upon more detailed examination, however, others have uncovered subtle delays and advances. 3, 19, 25 The clinical significance of the findings has yet to be firmly established for both short-and long-term outcomes. The preterm infant with an early gestational age and morbidity truly differs when compared with the appropriate, asymptomatic preterm control. Catch-up details may provide clues to long-term outcome. Sex and exposure to steroids do not appear to affect sleep and waking in the asymptomatic preterm infant, but maternal smoking and SGA status have subtle impacts on sleep architecture.
